Vaccines

May 16, 2013

Grant targets new therapies for Ebola, Marburg viruses

Vanderbilt’s James Crowe Jr., M.D., and a collaborator in Texas have been awarded a $4.4 million grant from the U.S. Department of Defense to study new ways to treat and prevent Ebola and Marburg viruses.

By VUMC News and Communications
July 19, 2012

Long antibodies better against HIV

Understanding how antibodies with long “loops” form may be important for HIV vaccine development.

By Leigh MacMillan
April 27, 2012

Dengue antibodies give vaccine leads

New information may help speed development of a vaccine or treatment for dengue fever.

By VUMC News and Communications
June 17, 2008

$2.4 million NIH grant puts Children’s Hospital researcher at forefront of new direction in HIV research

After recent efforts to develop a vaccine to protect against AIDS proved ineffective, the National Institutes of Health announced a change in research direction; and it\’s one that will involve the lab of James Crowe, M.D., professor of Pediatrics, Microbiology and Immunology at the Monroe Carell Jr. Children\’s Hospital at Vanderbilt.

By VUMC News and Communications
September 27, 2004

Vanderbilt University Medical Center Launches Genital Herpes Vaccine Trial

Vanderbilt University Medical Center researchers are launching a clinical trial of Herpavac, a new genital herpes vaccine that has proven effective in previous clinical trials in preventing the spread of the herpes simplex virus in women.

By VUMC News and Communications
1 … 11 12 13 14